title: ATF4 promotes bone angiogenesis by increasing VEGF expression and release in the bone environment.
abstract: Activating transcription factor 4 (ATF4) is a critical transcription factor for bone remodeling; however, its role in bone angiogenesis has not been established. Here we show that ablation of the Atf4 gene expression in mice severely impaired skeletal vasculature and reduced microvascular density of the bone associated with dramatically decreased expression of hypoxia-inducible factor 1α (HIF-1α) and vascular endothelial growth factor (VEGF) in osteoblasts located on bone surfaces. Results from in vivo studies revealed that hypoxia/reoxygenation induction of HIF-1α and VEGF expression leading to bone angiogenesis, a key adaptive response to hypoxic conditions, was severely compromised in mice lacking the Atf4 gene. Loss of ATF4 completely prevented endothelial sprouting from embryonic metatarsals, which was restored by addition of recombinant human VEGF protein. In vitro studies revealed that ATF4 promotion of HIF-1α and VEGF expression in osteoblasts was highly dependent upon the presence of hypoxia. ATF4 interacted with HIF-1α in hypoxic osteoblasts, and loss of ATF4 increased HIF-1α ubiquitination and reduced its protein stability without affecting HIF-1α mRNA stability and protein translation. Loss of ATF4 increased the binding of HIF-1α to prolyl hydroxylases, the enzymes that hydroxylate HIF-1a protein and promote its proteasomal degradation via the pVHL pathway. Furthermore, parathyroid hormone-related protein (PTHrP) and receptor activator of NF-κB ligand (RANKL), both well-known activators of osteoclasts, increased release of VEGF from the bone matrix and promoted angiogenesis through the protein kinase C- and ATF4-dependent activation of osteoclast differentiation and bone resorption. Thus, ATF4 is a new key regulator of the HIF/VEGF axis in osteoblasts in response to hypoxia and of VEGF release from bone matrix, two critical steps for bone angiogenesis.
authors: College of Life Sciences, Nankai University, Tianjin 300071, China.|Department of Biochemistry, Rush University Medical Center, Chicago, IL 60612.
authors: Ke
authors: K
authors: Zhu
authors: College of Life Sciences, Nankai University, Tianjin 300071, China.|Department of Biochemistry, Rush University Medical Center, Chicago, IL 60612.
authors: Hongli
authors: H
authors: Jiao
authors: College of Life Sciences, Nankai University, Tianjin 300071, China.
authors: Shuai
authors: S
authors: Li
authors: Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15240.
authors: Huiling
authors: H
authors: Cao
authors: Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15240.
authors: Deborah L
authors: DL
authors: Galson
authors: College of Life Sciences, Nankai University, Tianjin 300071, China.
authors: Zhongfang
authors: Z
authors: Zhao
authors: College of Life Sciences, Nankai University, Tianjin 300071, China.
authors: Xi
authors: X
authors: Zhao
authors: Department of Biochemistry, Rush University Medical Center, Chicago, IL 60612.
authors: Yumei
authors: Y
authors: Lai
authors: Department of Surgery, University of Pittsburgh, Pittsburgh, PA 15240.
authors: Jie
authors: J
authors: Fan
authors: Department of Biochemistry, Rush University Medical Center, Chicago, IL 60612.
authors: Hee-Jeong
authors: HJ
authors: Im
authors: Department of Biochemistry, Rush University Medical Center, Chicago, IL 60612.
authors: Di
authors: D
authors: Chen
authors: Department of Biochemistry, Rush University Medical Center, Chicago, IL 60612.
authors: Guozhi
authors: G
authors: Xiao
mesh_terms: D051701:Activating Transcription Factor 4 / Q000172:deficiency / Q000378:metabolism*; D000818:Animals; D001857:Bone Matrix / Q000187:drug effects / Q000378:metabolism; D001862:Bone Resorption / Q000473:pathology; D001842:Bone and Bones / Q000098:blood supply* / Q000187:drug effects / Q000378:metabolism; D015687:Cell Hypoxia / Q000187:drug effects / Q000235:genetics; D004727:Endothelium / Q000187:drug effects / Q000254:growth & development / Q000378:metabolism; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000235:genetics / Q000378:metabolism; D008682:Metatarsal Bones / Q000098:blood supply / Q000378:metabolism; D051379:Mice; D018919:Neovascularization, Physiologic / Q000187:drug effects / Q000235:genetics; D010006:Osteoblasts / Q000187:drug effects / Q000378:metabolism; D010010:Osteoclasts / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D010100:Oxygen / Q000494:pharmacology; D064828:Prolyl Hydroxylases / Q000378:metabolism; D011485:Protein Binding / Q000187:drug effects / Q000235:genetics; D014176:Protein Biosynthesis / Q000187:drug effects / Q000235:genetics; D011493:Protein Kinase C / Q000378:metabolism; D055550:Protein Stability / Q000187:drug effects; D020871:RNA Stability / Q000187:drug effects / Q000235:genetics; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D054875:Ubiquitination / Q000187:drug effects; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism*; D051794:Von Hippel-Lindau Tumor Suppressor Protein / Q000378:metabolism
chemical_list: C081452:Atf4 protein, mouse; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D012333:RNA, Messenger; D042461:Vascular Endothelial Growth Factor A; C467480:vascular endothelial growth factor A, mouse; D051701:Activating Transcription Factor 4; D064828:Prolyl Hydroxylases; D051794:Von Hippel-Lindau Tumor Suppressor Protein; D011493:Protein Kinase C; D010100:Oxygen
keywords: ANGIOGENESIS; ATF4; BONE; OSTEOBLASTS; OSTEOCLASTS; VEGF
references: Genes Dev. 2001 Oct 15;15(20):2675-86
references: 11641274
references: Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):7987-92
references: 9653127
references: PLoS One. 2009 Oct 23;4(10):e7583
references: 19851510
references: Nature. 2005 Mar 24;434(7032):514-20
references: 15724149
references: FASEB J. 2001 Nov;15(13):2445-53
references: 11689469
references: PLoS One. 2010 Sep 02;5(9):
references: 20824063
references: J Bone Miner Res. 2008 May;23(5):596-609
references: 18433297
references: Clin Orthop Relat Res. 2011 Nov;469(11):3118-26
references: 21409457
references: Mol Cancer Res. 2010 Apr;8(4):459-70
references: 20332212
references: J Cell Biochem. 1997 Jul 1;66(1):1-8
references: 9215522
references: Nature. 1999 May 20;399(6733):271-5
references: 10353251
references: Cell. 1997 May 30;89(5):765-71
references: 9182764
references: Cell. 1997 May 30;89(5):747-54
references: 9182762
references: Cell. 1997 Apr 18;89(2):309-19
references: 9108485
references: Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):9656-61
references: 12118119
references: PLoS One. 2009 Sep 03;4(9):e6896
references: 19727403
references: J Clin Invest. 2007 Jun;117(6):1616-26
references: 17549257
references: Cell. 1998 Apr 17;93(2):165-76
references: 9568710
references: BMC Med. 2010 Mar 24;8:19
references: 20334641
references: Endocrinology. 2008 Apr;149(4):1960-8
references: 18187540
references: J Bone Joint Surg Am. 1972 Mar;54(2):323-32
references: 4651264
references: J Clin Invest. 2012 Sep;122(9):3101-13
references: 22886301
references: PLoS One. 2010 Mar 08;5(3):e9575
references: 20221394
references: J Biol Chem. 2005 Sep 2;280(35):30689-96
references: 16000305
references: Arterioscler Thromb Vasc Biol. 2010 May;30(5):1007-13
references: 20185790
references: Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):686-91
references: 18184809
references: J Biol Chem. 2011 May 27;286(21):19149-58
references: 21471200
references: Cell Metab. 2006 Dec;4(6):441-51
references: 17141628
references: Genes Dev. 2002 Jun 15;16(12):1466-71
references: 12080085
references: Mol Endocrinol. 1997 Jul;11(8):1103-13
references: 9212058
references: Blood. 2010 Jan 7;115(1):140-9
references: 19887675
references: J Clin Invest. 2010 Aug;120(8):2755-66
references: 20628199
references: J Bone Miner Res. 2009 Aug;24(8):1347-53
references: 19558314
references: Genes Dev. 2003 Nov 1;17(21):2614-23
references: 14597660
references: Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3597-602
references: 9520411
references: PLoS One. 2009;4(4):e5077
references: 19347037
references: J Biol Chem. 2002 Nov 1;277(44):41750-5
references: 12205091
references: Cell. 1997 May 30;89(5):773-9
references: 9182765
references: Mol Cancer Ther. 2004 May;3(5):647-54
references: 15141023
references: EMBO J. 1998 Nov 16;17(22):6573-86
references: 9822602
references: Sci STKE. 2005 Oct 18;2005(306):re12
references: 16234508
references: Cell. 1997 May 30;89(5):755-64
references: 9182763
references: Mech Dev. 2002 Feb;111(1-2):61-73
references: 11804779
references: J Biol Chem. 2005 May 27;280(21):20331-9
references: 15788408
references: J Cell Biochem. 2008 Oct 15;105(3):885-95
references: 18729081
references: J Biol Chem. 2008 Feb 29;283(9):5542-53
references: 18171674
references: J Biol Chem. 2004 Nov 5;279(45):47109-14
references: 15377660
references: Cancer Res. 2009 Mar 1;69(5):1836-43
references: 19244104
references: J Bone Miner Res. 1999 Jun;14(6):893-903
references: 10352097
references: Nat Rev Cancer. 2002 Sep;2(9):673-82
references: 12209156
references: Int J Oral Maxillofac Surg. 2006 Mar;35(3):231-6
references: 16185845
references: Ann N Y Acad Sci. 2007 Nov;1116:149-64
references: 18083926